BBIO – Encaleret – ADH1 – ENDO 2025 – Phase 2 Over 42 Months Data Results

BridgeBio Pharma Inc. published this content on July 14, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on July 14, 2025 at 21:39 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io